Search Results - "Väänänen, H. Kalervo"

Refine Results
  1. 1

    The critical role of IL-34 in osteoclastogenesis by Chen, Zhi, Buki, Kalman, Vääräniemi, Jukka, Gu, Guoliang, Väänänen, H Kalervo

    Published in PloS one (08-04-2011)
    “…It has been widely believed that the cytokines required for osteoclast formation are M-CSF (also known as CSF-1) and RANKL. Recently, a novel cytokine,…”
    Get full text
    Journal Article
  2. 2

    Osteoclast lineage and function by Väänänen, H. Kalervo, Laitala-Leinonen, Tiina

    Published in Archives of biochemistry and biophysics (15-05-2008)
    “…Osteoclasts are members of the monocyte/macrophage lineage and are formed by cellular fusions from their mononuclear precursors. Their differentiation is…”
    Get full text
    Journal Article
  3. 3

    Mesenchymal stem cells by Väänänen, H Kalervo

    Published in Annals of medicine (Helsinki) (01-01-2005)
    “…About 40 years ago Friedenstein described stromal cells in the bone marrow that were spindle shaped and proliferate to form colonies. These cells attach to…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Estrogen and Testosterone Use Different Cellular Pathways to Inhibit Osteoclastogenesis and Bone Resorption by Michael, Husheem, Härkönen, Pirkko L, Väänänen, H Kalervo, Hentunen, Teuvo A

    Published in Journal of bone and mineral research (01-12-2005)
    “…Using human peripheral blood CD14+ osteoclast precursors, we show that testosterone directly inhibits osteoclast formation and bone resorption at physiological…”
    Get full text
    Journal Article
  6. 6

    Associations Between Homocysteine, Bone Turnover, BMD, Mortality, and Fracture Risk in Elderly Women by Gerdhem, Paul, Ivaska, Kaisa K, Isaksson, Anders, Pettersson, Kim, Väänänen, H Kalervo, Obrant, Karl J, Åkesson, Kristina

    Published in Journal of bone and mineral research (01-01-2007)
    “…Homocysteine has been suggested to be a risk factor for fracture, but the causal relationship is not clear. In 996 women from the OPRA study, high homocysteine…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Degradation of hydroxyapatite in vivo and in vitro requires osteoclastic sodium-bicarbonate co-transporter NBCn1 by Riihonen, Riikka, Nielsen, Søren, Väänänen, H. Kalervo, Laitala-Leinonen, Tiina, Kwon, Tae-Hwan

    Published in Matrix biology (01-05-2010)
    “…Dissolution of the inorganic bone matrix releases not only calcium and phosphate ions, but also bicarbonate. Electroneutral sodium-bicarbonate co-transporter…”
    Get full text
    Journal Article
  9. 9

    Regulation of Osteoblast Differentiation: A Novel Function for Fibroblast Growth Factor 8 by Valta, Maija P, Hentunen, Teuvo, Qu, Qiang, Valve, Eeva M, Harjula, Anna, Seppänen, Jani A, Väänänen, H. Kalervo, Härkönen, Pirkko L

    Published in Endocrinology (Philadelphia) (01-05-2006)
    “…Several members of the fibroblast growth factor (FGF) family have an important role in the development of skeletal tissues. FGF-8 is widely expressed in the…”
    Get full text
    Journal Article
  10. 10

    Biochemical Markers of Bone Metabolism and Prediction of Fracture in Elderly Women by Gerdhem, Paul, Ivaska, Kaisa K, Alatalo, Sari L, Halleen, Jussi M, Hellman, Jukka, Isaksson, Anders, Pettersson, Kim, Väänänen, H Kalervo, Åkesson, Kristina, Obrant, Karl J

    Published in Journal of bone and mineral research (01-03-2004)
    “…We studied the ability of various markers of bone turnover to predict fracture in 1040 randomly recruited 75‐year‐old women. A total of 178 of the women…”
    Get full text
    Journal Article
  11. 11

    Serial Assessment of Serum Bone Metabolism Markers Identifies Women with the Highest Rate of Bone Loss and Osteoporosis Risk by Ivaska, Kaisa K., Lenora, Janaka, Gerdhem, Paul, Åkesson, Kristina, Väänänen, H. Kalervo, Obrant, Karl J.

    “…Context: One of the important challenges in the management of osteoporosis is to identify women who are at high risk of developing osteoporosis and fragility…”
    Get full text
    Journal Article
  12. 12

    Release of Intact and Fragmented Osteocalcin Molecules from Bone Matrix during Bone Resorption in Vitro by Ivaska, Kaisa K, Hentunen, Teuvo A, Vääräniemi, Jukka, Ylipahkala, Hannele, Pettersson, Kim, Väänänen, H Kalervo

    Published in The Journal of biological chemistry (30-04-2004)
    “…Osteocalcin detected from serum samples is considered a specific marker of osteoblast activity and bone formation rate. However, osteocalcin embedded in bone…”
    Get full text
    Journal Article
  13. 13

    Bone Marrow Cell Differentiation Induced by Mechanically Damaged Osteocytes in 3D Gel‐Embedded Culture by Kurata, Kosaku, Heino, Terhi J, Higaki, Hidehiko, Väänänen, H Kalervo

    Published in Journal of bone and mineral research (01-04-2006)
    “…Osteocytes are suggested to have a crucial role in the initial resorptive phase of bone turnover after microdamage. To study the role of osteocytes in targeted…”
    Get full text
    Journal Article
  14. 14

    The effects of acute hyperinsulinemia on bone metabolism by K Ivaska, Kaisa, K Heliövaara, Maikki, Ebeling, Pertti, Bucci, Marco, Huovinen, Ville, Kalervo Väänänen, H, Nuutila, Pirjo, A Koistinen, Heikki

    Published in Endocrine Connections (01-09-2015)
    “…Insulin signaling in bone-forming osteoblasts stimulates bone formation and promotes the release of osteocalcin (OC) in mice. Only a few studies have assessed…”
    Get full text
    Journal Article
  15. 15

    Membrane-bound carbonic anhydrases in osteoclasts by Riihonen, Riikka, Supuran, Claudiu T, Parkkila, Seppo, Pastorekova, Silvia, Väänänen, H. Kalervo, Laitala-Leinonen, Tiina

    Published in Bone (New York, N.Y.) (01-04-2007)
    “…Abstract Osteoclasts are multinucleated bone-resorbing cells that use multiple pH regulation mechanisms to create an acidic pH in the resorption lacuna…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells by Kallio, Anu, Guo, Tao, Lamminen, Elisa, Seppänen, Jani, Kangas, Lauri, Väänänen, H. Kalervo, Härkönen, Pirkko

    Published in Molecular and cellular endocrinology (16-07-2008)
    “…In the current work, we compared the ability of 17β-estradiol (E 2) and the selective estrogen receptor modulators (SERMs), tamoxifen (Tam), raloxifene (Ral)…”
    Get full text
    Journal Article
  18. 18

    Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors by Tuomela, Johanna, Valta, Maija, Seppänen, Jani, Tarkkonen, Kati, Väänänen, H Kalervo, Härkönen, Pirkko

    Published in BMC cancer (12-10-2009)
    “…Prostate cancer metastasizes to regional lymph nodes and distant sites but the roles of lymphatic and hematogenous pathways in metastasis are not fully…”
    Get full text
    Journal Article
  19. 19

    Urinary Osteocalcin as a Marker of Bone Metabolism by Ivaska, Kaisa K, Kakonen, Sanna-Maria, Gerdhem, Paul, Obrant, Karl J, Pettersson, Kim, Vaananen, H. Kalervo

    Published in Clinical chemistry (Baltimore, Md.) (01-03-2005)
    “…Osteocalcin (OC) is produced by osteoblasts during bone formation, and circulating OC has been used in clinical investigations as a marker of bone metabolism…”
    Get full text
    Journal Article
  20. 20

    A Rationale for Osteoclast Selectivity of Inhibiting the Lysosomal V-ATPase a3 Isoform by Nyman, Jonas K. E., Väänänen, H. Kalervo

    Published in Calcified tissue international (01-09-2010)
    “…Osteoclastic bone resorption can be completely abolished by inhibiting the vacuolar H + -ATPase (V-ATPase), a proton pump composed of at least 12 different…”
    Get full text
    Journal Article